Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

MENTOR · Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training

HORIZONStatus: SIGNED1 January 202531 December 2028EU funding €3,953,988Call HORIZON-MSCA-2023-DN-01

MENTOR is a multi-disciplinary training network which focuses on the mTOR pathway, a central mechanistic hub that integrates nutritional cues and controls cell growth and metabolism. Aberrant activation of mTOR underlies monogenic diseases with broad spectrum of pathological manifestations, including tissue overgrowth, polycystic kidneys and neuropsychiatric disorders affecting around two million of people worldwide. To avoid the medical errancy of patients in different clinical departments and surgical mutilations, approaches of personalized medicine depending on the genetic landscape need to be implemented, taking advantage of suitable pharmacological products. The overall goal of the MENTOR research program is to: delineate molecular mechanisms of fundamental and aberrant mTOR functions, preclinically decipher the pathophysiology of mTOR, develop a novel arsenal of drugs to selectively target the pathway and provide proof-of-concept support for such interventions. This ambition can only be achieved by the multidisciplinary research program that MENTOR has conceived, through the training of a new generation of scientists at Graduate Schools of biology, pharmacy, chemistry or medicine that will become the leaders of mTOR research in both public and private sectors. MENTOR will establish a collaborative and efficient network from academia to industry, involving patient associations and clinicians with impact on scientific community and society.

Consortium · 26 organisations

coordinator

UNIVERSITE PARIS CITE

FR · €565,387

participant

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

ES · €251,971

participant

MIMETAS BV

NL · €274,370

participant

MIEDZYNARODOWY INSTYTUT MECHANIZMOW I MASZYN MOLEKULARNYCH POLSKIEJ AKADEMII NAUK

PL · €226,512

participant

FONDAZIONE TELETHON ETS

IT · €259,438

participant

PD-VALUE BV

NL · €274,370

associatedPartner

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR

associatedPartner

UNIVERSITAT BASEL

CH

associatedPartner

The Myrovlytis Trust

UK

associatedPartner

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

FR

associatedPartner

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II

IT

participant

IDRYMA TECHNOLOGIAS KAI EREVNAS

EL · €240,098

participant

INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE

FR · €282,694

associatedPartner

European Tuberous Sclerosis Complex Association (e-tsc)

DE

associatedPartner

BIOSOLVEIT GMBH

DE

associatedPartner

Topadur Pharma AG

CH

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €274,370

participant

UNIVERSITAETSKLINIKUM ESSEN

DE · €521,078

associatedPartner

Cell Signaling Technology, Inc.

US

associatedPartner

PANEPISTIMIO IOANNINON

EL

participant

EBERHARD KARLS UNIVERSITAET TUEBINGEN

DE · €521,078

associatedPartner

UNIVERSIDAD AUTONOMA DE MADRID

ES

participant

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €262,620

associatedPartner

UNIVERSITE DE FRIBOURG

CH

associatedPartner

MIEDZYNARODOWY INSTYTUT BIOLOGII MOLEKULARNEJ I KOMORKOWEJ W WARSZAWIE

PL

associatedPartner

SORBONNE UNIVERSITE

FR

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.